PRESS RELEASE Mannatech, Inc. Adds Senior Management Talent
PRESS RELEASE Mannatech, Inc. Adds Senior Management Talent:
"Mannatech, Inc. (NASDAQ: MTEX) today announced two new appointments to its senior management team that will further strengthen the Company's top talent and alignment with key growth objectives of international expansion and focus on proprietary technology.
Effective immediately, John Price joins the company as its new President of International Operations and Robert Sinnott, MNS, Ph.D. joins the company as Chief Science Officer and Vice President of R&D. John Price comes to Mannatech having previously worked at Herbalife, Incorporated (NYSE: HLF), a $1.8 billion global nutritional company, where he served as Senior Vice President of Worldwide Administration. In his new capacity, John will spearhead Mannatech's international expansion to reach new markets and new customers as well as continue to grow the existing international businesses. Dr. Sinnott, founder of Larrea BioSciences Corporation (OTC BB: LRRA) and holder of five U.S. patents, will lead the development of innovative new healthcare products that fill a need in today's marketplace. "
"Mannatech, Inc. (NASDAQ: MTEX) today announced two new appointments to its senior management team that will further strengthen the Company's top talent and alignment with key growth objectives of international expansion and focus on proprietary technology.
Effective immediately, John Price joins the company as its new President of International Operations and Robert Sinnott, MNS, Ph.D. joins the company as Chief Science Officer and Vice President of R&D. John Price comes to Mannatech having previously worked at Herbalife, Incorporated (NYSE: HLF), a $1.8 billion global nutritional company, where he served as Senior Vice President of Worldwide Administration. In his new capacity, John will spearhead Mannatech's international expansion to reach new markets and new customers as well as continue to grow the existing international businesses. Dr. Sinnott, founder of Larrea BioSciences Corporation (OTC BB: LRRA) and holder of five U.S. patents, will lead the development of innovative new healthcare products that fill a need in today's marketplace. "